Most Clicked StoriesMore >


PCMA questions whether CMS study is prelude to interfering in pharmacy contracts

PCMA SmartBrief | Dec 17, 2014

A CMS study on pharmacy access in Medicare Part D might open the door for the agency to revisit proposals that likely violate the noninterference clause in the Part D law, PCMA says. Given the controversy surrounding the agency's previous proposal on preferred pharmacy networks, PCMA also asked whether the CMS would consult Congress on the new research when lawmakers return. InsideHealthPolicy.com (subscription required) (12/17)


CMS to discuss pharmacy access study findings

PCMA SmartBrief | Dec 15, 2014

Industry expert says CMS pharmacy access study is limited

PCMA SmartBrief | Dec 19, 2014

Many hepatitis patients don't receive treatment

PCMA SmartBrief | Dec 19, 2014

Leukemia drug joins trend of costly meds at $178,000

PCMA SmartBrief | Dec 18, 2014

FDA policies that boost competition would lower drug prices

PCMA SmartBrief | Dec 16, 2014

PCMA: CMS should brief Congress before attempting to change Part D

PCMA SmartBrief | Dec 18, 2014

Corporations approach private insurance exchanges with caution

PCMA SmartBrief | Dec 16, 2014

PCMA: Is CMS' study on Medicare Part D preferred pharmacies a pretext for major changes?

PCMA SmartBrief | Dec 17, 2014

Report: Global drug sales may fall $65 billion by 2019

PCMA SmartBrief | Dec 15, 2014


Find PCMA SmartBrief Issues by Date:





Sign up for PCMA SmartBrief



Designed specifically for PBM industry professionals, PCMA SmartBrief is a FREE, daily e-mail newsletter. It provides the the most relevant and actionable PBM industry news in a quick, easy to read format. Learn more